If you are looking for a reliable peer-reviewed journal in science and medicine news, Oncotarget is one of the most trusted sources. Oncotarget is a peer-reviewed journal edited by chief editors Mikhail Blagosklonny and Andrei V Gudkov and is published by Impact Journal. This journal focuses on oncology and other science fields.
It would be an uphill task to get news and updates on the developments taking place in science especially if your college has not subscribed to the available paid newsletters. However, with Oncotraget, it is possible for the researchers to access developing news in the field of oncology and medicine. The information provided by Oncotarget is usually found in expensive and inaccessible weekly magazines and newsletters. This makes it difficult for many researchers and scholars to get updates on the new findings in the field of science. Oncotarget is also available on Dove Press.
Oncotarget is one of the many ways that can help science readers to keep up to date with the latest information. The online-published journal allows researchers to access recent information about anything in oncology and medicine. An online journal provides access to information for a wide audience since there are no barriers that would exist had the journal been printed and distributed to different physical locations. Oncotarget ensures that scholars can even access most scientific news from wherever they are.
Oncotarget focuses on providing readers with news about oncology as their main subject. However, it also provides updates on other areas of science alongside the news on oncology. Such fields include cell biology, microbiology, and pharmacology, among many other fields. As a multi disciplinary journal, it allows readers to have free access. It is a peer-reviewed journal that is released on a weekly basis and is trustworthy. You would also be able to access new information on cancer treatment and therapies. Follow Oncotarget journal on Twitter.
The journal received a 5.008 impact factor and won many awards in 2015-2016 for its efficiency in spreading news on science, specifically on oncology. Unlike many paid journals and newsletters, Oncotarget remains free, trustworthy, and the best option for researchers and readers.